1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Herpes Infections Global Clinical Trials Review, H2, 2014

Herpes Infections Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • GlobalData
  • -
  • 128 pages

Herpes Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Herpes Infections Global Clinical Trials Review, H2, 2014" provides data on the Herpes Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Herpes Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Herpes Infections Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Herpes Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Herpes Infections 25
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Herpes Infections Therapeutics Clinical Trials 34
Prominent Drugs 35
Latest Clinical Trials News on Herpes Infections 36
Oct 08, 2014: NanoBio To Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Merck and Co., Inc. 44
Clinical Trial Overview of Merck and Co., Inc. 44
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48
Novartis AG 52
Clinical Trial Overview of Novartis AG 52
Astellas Pharma Inc. 54
Clinical Trial Overview of Astellas Pharma Inc. 54
Sanofi 55
Clinical Trial Overview of Sanofi 55
Pfizer Inc. 56
Clinical Trial Overview of Pfizer Inc. 56
AstraZeneca PLC 57
Clinical Trial Overview of AstraZeneca PLC 57
Vical Incorporated 59
Clinical Trial Overview of Vical Incorporated 59
Gilead Sciences, Inc. 60
Clinical Trial Overview of Gilead Sciences, Inc. 60
Clinical Trial Overview of Top Institutes / Government 61
The National Institute of Allergy and Infectious Diseases 61
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 61
National Cancer Institute 66
Clinical Trial Overview of National Cancer Institute 66
University of Washington 68
Clinical Trial Overview of University of Washington 68
National Heart, Lung, and Blood Institute 69
Clinical Trial Overview of National Heart, Lung, and Blood Institute 69
National Center for Research Resources 70
Clinical Trial Overview of National Center for Research Resources 70
National Eye Institute 71
Clinical Trial Overview of National Eye Institute 71
Baylor College of Medicine 72
Clinical Trial Overview of Baylor College of Medicine 72
University of California, San Francisco 73
Clinical Trial Overview of University of California, San Francisco 73
University of Alabama at Birmingham 74
Clinical Trial Overview of University of Alabama at Birmingham 74
Memorial Sloan Kettering Cancer Center 75
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 75
Five Key Clinical Profiles 76
Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 128
Contact Us 128
Disclaimer 128
Source 128

List of Tables

Herpes Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Herpes Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Herpes Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Herpes Infections Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Herpes Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Herpes Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 32
Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 37
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 44
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 48
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 52
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 54
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 55
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 56
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 57
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Vical Incorporated, 2014* 59
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 60
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 61
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 66
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 68
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 69
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 70
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 71
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 72
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 73
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 74
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 75

List of Figures

Herpes Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Herpes Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Herpes Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 32
Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
GlobalData Methodology 127

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Liver Fibrosis Global Clinical Trials Review, H2, 2016

Liver Fibrosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Liver Fibrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Fibrosis clinical ...

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016" provides an overview ...

Anterior Uveitis Global Clinical Trials Review, H2, 2016

Anterior Uveitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Anterior Uveitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Anterior Uveitis Global Clinical Trials Review, H2, 2016" provides an overview of Anterior Uveitis ...

The Generic Injectables Market

February 2017 $ 3850

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.